D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 77 Citations 35,862 194 World Ranking 2919 National Ranking 203

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Enzyme
  • Biochemistry

Albena T. Dinkova-Kostova mainly investigates Biochemistry, KEAP1, Transcription factor, Cell biology and Sulforaphane. Her work on Biochemistry deals in particular with Antioxidant, Enzyme inducer, Oxidative stress, Enzyme and Cysteine. Her KEAP1 research is multidisciplinary, relying on both Oxidoreductase, Cell, Ubiquitin ligase and Inducer.

The various areas that Albena T. Dinkova-Kostova examines in her Transcription factor study include Ubiquitin and Signal transducing adaptor protein. Her Cell biology research is multidisciplinary, incorporating perspectives in Apoptosis, Endogeny, Transcriptional regulation and Angiogenesis. Her work is dedicated to discovering how Sulforaphane, Isothiocyanate are connected with Pharmacology, Broccoli sprouts and Disease and other disciplines.

Her most cited work include:

  • Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants (1523 citations)
  • The Nrf2 regulatory network provides an interface between redox and intermediary metabolism (953 citations)
  • Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. (792 citations)

What are the main themes of her work throughout her whole career to date?

Her main research concerns Biochemistry, KEAP1, Transcription factor, Oxidative stress and Cell biology. Her work carried out in the field of KEAP1 brings together such families of science as Cancer research, Ubiquitin, Cytoprotection, Oxidative phosphorylation and Cysteine. Her study in Transcription factor is interdisciplinary in nature, drawing from both Ubiquitin ligase and HSF1.

Her study looks at the intersection of Oxidative stress and topics like Inflammation with Biomarker. Her research investigates the link between Cell biology and topics such as Downregulation and upregulation that cross with problems in Carcinogenesis. Her Sulforaphane research focuses on Pharmacology and how it connects with Broccoli sprouts and Isothiocyanate.

She most often published in these fields:

  • Biochemistry (55.88%)
  • KEAP1 (45.96%)
  • Transcription factor (44.49%)

What were the highlights of her more recent work (between 2018-2021)?

  • Cancer research (26.10%)
  • Oxidative stress (36.40%)
  • Inflammation (19.49%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Cancer research, Oxidative stress, Inflammation, Transcription factor and KEAP1. Albena T. Dinkova-Kostova combines subjects such as Cell, Cancer cell, Cancer, Carcinogenesis and Kinase with her study of Cancer research. The concepts of her Oxidative stress study are interwoven with issues in DNA damage, Toxicity and In vivo.

Her biological study spans a wide range of topics, including Swietenine, HMOX1, Biomarker, Arsenic toxicity and Pharmacology. Her studies deal with areas such as HEK 293 cells, Transcription and Cell biology as well as Transcription factor. Her research in KEAP1 intersects with topics in Cytoprotection, Downregulation and upregulation and Cysteine.

Between 2018 and 2021, her most popular works were:

  • Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases (291 citations)
  • Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases (291 citations)
  • Oxidative Stress in Cancer. (77 citations)

In her most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Cancer

Albena T. Dinkova-Kostova mainly focuses on Inflammation, Oxidative stress, Cytoprotection, Transcription factor and KEAP1. Her Inflammation study integrates concerns from other disciplines, such as Heat shock protein and Sulforaphane. Her Oxidative stress research is multidisciplinary, incorporating perspectives in Immune dysregulation, Immunology, Peripheral blood mononuclear cell, Hsp70 and Biomarker.

Her studies in Transcription factor integrate themes in fields like AMPK, Ubiquitin ligase and Cell biology. Her Cell biology study combines topics from a wide range of disciplines, such as Carcinogenesis, Cancer cell, HSF1 and Pentose phosphate pathway. She has included themes like Cancer research and Bardoxolone methyl in her KEAP1 study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif.
Autophagy (2021)

8964 Citations

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

Albena T. Dinkova-Kostova;W. David Holtzclaw;Robert N. Cole;Ken Itoh.
Proceedings of the National Academy of Sciences of the United States of America (2002)

1977 Citations

The Nrf2 regulatory network provides an interface between redox and intermediary metabolism

John D. Hayes;Albena T. Dinkova-Kostova.
Trends in Biochemical Sciences (2014)

1170 Citations

Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.

Nobunao Wakabayashi;Albena T. Dinkova-Kostova;W. David Holtzclaw;Moon Il Kang.
Proceedings of the National Academy of Sciences of the United States of America (2004)

1083 Citations

The cytoprotective role of the Keap1–Nrf2 pathway

Liam Baird;Albena T. Dinkova-Kostova;Albena T. Dinkova-Kostova;Albena T. Dinkova-Kostova.
Archives of Toxicology (2011)

871 Citations

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.

Evanna L Mills;Dylan G Ryan;Hiran A Prag;Dina Dikovskaya.
Nature (2018)

825 Citations

Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups

Albena T. Dinkova-Kostova;Michael A. Massiah;Richard E. Bozak;Ronald J. Hicks.
Proceedings of the National Academy of Sciences of the United States of America (2001)

642 Citations

Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress

Albena T. Dinkova-Kostova;Karen T. Liby;Katherine K. Stephenson;W. David Holtzclaw.
Proceedings of the National Academy of Sciences of the United States of America (2005)

621 Citations

Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease

Lauren E. Tebay;Holly Robertson;Stephen T. Durant;Steven R. Vitale.
Free Radical Biology and Medicine (2015)

619 Citations

NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector

Albena T. Dinkova-Kostova;Paul Talalay.
Archives of Biochemistry and Biophysics (2010)

574 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Albena T. Dinkova-Kostova

Masayuki Yamamoto

Masayuki Yamamoto

Tohoku University

Publications: 163

Thomas W. Kensler

Thomas W. Kensler

Fred Hutchinson Cancer Research Center

Publications: 91

Donna D. Zhang

Donna D. Zhang

University of Arizona

Publications: 62

Vittorio Calabrese

Vittorio Calabrese

University of Catania

Publications: 51

Michael B. Sporn

Michael B. Sporn

Dartmouth College

Publications: 49

John D. Hayes

John D. Hayes

University of Dundee

Publications: 47

Ah-Ng Tony Kong

Ah-Ng Tony Kong

Rutgers, The State University of New Jersey

Publications: 44

José Pedraza-Chaverri

José Pedraza-Chaverri

National Autonomous University of Mexico

Publications: 43

Antonio Cuadrado

Antonio Cuadrado

Spanish National Research Council

Publications: 41

Hozumi Motohashi

Hozumi Motohashi

Tohoku University

Publications: 33

Ken Itoh

Ken Itoh

Hirosaki University

Publications: 33

Edward J. Calabrese

Edward J. Calabrese

University of Massachusetts Amherst

Publications: 33

Young-Joon Surh

Young-Joon Surh

Seoul National University

Publications: 32

Renato Iori

Renato Iori

The Canadian Real Estate Association

Publications: 29

John D. Groopman

John D. Groopman

Johns Hopkins University

Publications: 28

Roderick H. Dashwood

Roderick H. Dashwood

Texas A&M University

Publications: 27

Trending Scientists

Jiafu Wan

Jiafu Wan

South China University of Technology

George Tauchen

George Tauchen

Duke University

Shengli Xie

Shengli Xie

Guangdong University of Technology

P.D. Dapkus

P.D. Dapkus

University of Southern California

Dai-Wen Pang

Dai-Wen Pang

Nankai University

Kazuo Soga

Kazuo Soga

Tokyo Institute of Technology

Lajos Haracska

Lajos Haracska

Biological Research Centre

Shinichi Kohsaka

Shinichi Kohsaka

Keio University

Arthur A. Guffanti

Arthur A. Guffanti

Icahn School of Medicine at Mount Sinai

William B. Curry

William B. Curry

Woods Hole Oceanographic Institution

Hans-Christen Hansson

Hans-Christen Hansson

Stockholm University

Peijun Shi

Peijun Shi

Beijing Normal University

John W. Rohrbaugh

John W. Rohrbaugh

Washington University in St. Louis

Kim Fromme

Kim Fromme

The University of Texas at Austin

Macartan Humphreys

Macartan Humphreys

Columbia University

Something went wrong. Please try again later.